Home
TEVA
TEVA News

Latest Teva Pharmaceutical Industries Limited (TEVA) News on May 22, 2025

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

GlobeNewswire

7 days ago

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Insider Monkey

7 days ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

7 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

Insider Monkey

8 days ago

Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

ACCESS Newswire

9 days ago

Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

Argus Research

9 days ago

Analyst Report: Teva Phar Inds Lt

Argus Research

9 days ago

Market Update: TEVA, ODFL, UBER, NET

Argus Research

9 days ago

Daily – Vickers Top Buyers & Sellers for 05/13/2025

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today

Motley Fool

10 days ago

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today

MT Newswires

10 days ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,097,304, According to a Recent SEC Filing

Teva's Bold $700M Gamble: Will It Be Enough to Rescue Its Plummeting Stock?

GuruFocus.com

10 days ago

Teva's Bold $700M Gamble: Will It Be Enough to Rescue Its Plummeting Stock?

MT Newswires

10 days ago

Teva Pharmaceutical Industries Shares Rise After JPMorgan Upgrades Rating

MT Newswires

10 days ago

JPMorgan Upgrades Teva Pharmaceutical Industries to Overweight From Neutral, Adjusts Price Target to $23 From $21

Morningstar Research

13 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (TEVA): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential

Insider Monkey

13 days ago

Teva Pharmaceutical Industries Limited (TEVA): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential

Teva Pharmaceutical Industries (NYSE:TEVA) Settles Class-Action Lawsuit For US$2 Million

Simply Wall St.

14 days ago

Teva Pharmaceutical Industries (NYSE:TEVA) Settles Class-Action Lawsuit For US$2 Million

Morningstar Research

14 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

TEVA Beats on Q1 Earnings, Expects $700M Cost Savings by 2027, Stock Up

Zacks

14 days ago

TEVA Beats on Q1 Earnings, Expects $700M Cost Savings by 2027, Stock Up

Teva Pharmaceutical Industries First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

14 days ago

Teva Pharmaceutical Industries First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Teva Pharmaceutical Industries Ltd (TEVA) Q1 2025 Earnings Call Highlights: Strong Growth in ...

GuruFocus.com

14 days ago

Teva Pharmaceutical Industries Ltd (TEVA) Q1 2025 Earnings Call Highlights: Strong Growth in ...

Why Teva Pharmaceutical Industries Limited (TEVA) Skyrocketed On Wednesday

Insider Monkey

14 days ago

Why Teva Pharmaceutical Industries Limited (TEVA) Skyrocketed On Wednesday

Teva Stock Jumps On Outlook. CEO Touts 'Real Clarity' On Future Profits.

Investor's Business Daily

15 days ago

Teva Stock Jumps On Outlook. CEO Touts 'Real Clarity' On Future Profits.

Why Teva Pharmaceutical Stock Is Soaring Today

Motley Fool

15 days ago

Why Teva Pharmaceutical Stock Is Soaring Today

MT Newswires

15 days ago

Sector Update: Health Care Stocks Gain Wednesday Afternoon

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says

Barrons.com

15 days ago

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says

MT Newswires

15 days ago

Sector Update: Health Care Stocks Advance Pre-Bell Wednesday

Teva Surges On Profit Guidance Boost Despite A Mixed First-Quarter Report

Investor's Business Daily

15 days ago

Teva Surges On Profit Guidance Boost Despite A Mixed First-Quarter Report

MT Newswires

15 days ago

Teva Pharmaceutical's Q1 Non-GAAP Earnings, Revenue Rise; 2025 Guidance Updated

Teva Pharm first-quarter profit rise tops estimates

Reuters

15 days ago

Teva Pharm first-quarter profit rise tops estimates

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

GlobeNewswire

15 days ago

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

GlobeNewswire

15 days ago

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

Thomson Reuters StreetEvents

16 days ago

Q1 2025 Corcept Therapeutics Inc Earnings Call

Argus Research

16 days ago

Wild April Restores Some Market Optimism

FDA approves Selarsdi injection as interchangeable with Stelara

Pharmaceutical Technology

16 days ago

FDA approves Selarsdi injection as interchangeable with Stelara

Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

17 days ago

Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?

MT Newswires

17 days ago

Sector Update: Health Care Stocks Decline Pre-Bell Monday

What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q1 Earnings

Zacks

17 days ago

What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q1 Earnings

MT Newswires

17 days ago

Sector Update: Health Care

MT Newswires

17 days ago

Teva, Alvotech Get FDA Approval for Selarsdi's Interchangeablity With Stelara

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

GlobeNewswire

17 days ago

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks

24 days ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Morningstar Research

a month ago

Analyst Report: Teva Pharmaceutical Industries Limited

Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now

Motley Fool

a month ago

Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals

Zacks

a month ago

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals

3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes

Zacks

a month ago

3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes

5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility

Motley Fool

a month ago

5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility

Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn

Insider Monkey

a month ago

Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn

Morningstar Research

a month ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention

Simply Wall St.

a month ago

Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Insider Monkey

a month ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

MT Newswires

a month ago

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT Newswires

a month ago

Teva Rolls Out Lower-Cost Soliris Biosimilar in US

MT Newswires

a month ago

Teva Pharmaceutical Industries Says US FDA Accepted its sBLA Filing for AJOVY

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

GlobeNewswire

a month ago

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

GlobeNewswire

a month ago

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva announces presentation of survey study on TEV-‘749

TipRanks

2 months ago

Teva announces presentation of survey study on TEV-‘749

Is Teva Pharmaceutical Industries (TEVA) the Most Undervalued Healthcare Stock to Buy According to Analysts?

Insider Monkey

2 months ago

Is Teva Pharmaceutical Industries (TEVA) the Most Undervalued Healthcare Stock to Buy According to Analysts?

MT Newswires

2 months ago

Teva Says Schizophrenia Trial Survey Results Show Patient Satisfaction With TEV-'749

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

GlobeNewswire

2 months ago

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

MT Newswires

2 months ago

Teva Pharmaceutical's Upcoming Cost-Optimization Plan May Offer Significant Benefits, UBS Says

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now

Motley Fool

2 months ago

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

GlobeNewswire

2 months ago

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

Teva Releases Q1 2025 Aide Memoire

GlobeNewswire

2 months ago

Teva Releases Q1 2025 Aide Memoire

Motley Fool

2 months ago

Billionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround Stocks

Was Jim Cramer Right About Teva Pharmaceutical Industries (TEVA)?

Insider Monkey

2 months ago

Was Jim Cramer Right About Teva Pharmaceutical Industries (TEVA)?

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

2 months ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Teva Pharmaceutical Industries (NYSE:TEVA) Sees 14% Stock Price Rise With FDA Acceptance Of New Drug Application

Simply Wall St.

2 months ago

Teva Pharmaceutical Industries (NYSE:TEVA) Sees 14% Stock Price Rise With FDA Acceptance Of New Drug Application

Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma

PR Newswire

2 months ago

Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma

Teva debuts global campaign encouraging people to get outside

Retail Dive

2 months ago

Teva debuts global campaign encouraging people to get outside

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $375,534, According to a Recent SEC Filing

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $999,425, According to a Recent SEC Filing

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $903,462, According to a Recent SEC Filing

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

GlobeNewswire

3 months ago

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

Why Axsome Therapeutics, Inc. (AXSM) is Skyrocketing So Far in 2025

Insider Monkey

3 months ago

Why Axsome Therapeutics, Inc. (AXSM) is Skyrocketing So Far in 2025

Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey

3 months ago

Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?

Teva targets schizophrenia to build on innovative medicines growth

Pharma Voice

3 months ago

Teva targets schizophrenia to build on innovative medicines growth

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey

3 months ago

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

GlobeNewswire

3 months ago

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Business Wire

3 months ago

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Teva Pharmaceutical Industries Limited (TEVA): Among Bourgeon Capital’s Top Stock Picks

Insider Monkey

3 months ago

Teva Pharmaceutical Industries Limited (TEVA): Among Bourgeon Capital’s Top Stock Picks

Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease

Benzinga

3 months ago

Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease

Teva and Alvotech launch ustekinumab biosimilar injection in US

Pharmaceutical Technology

3 months ago

Teva and Alvotech launch ustekinumab biosimilar injection in US

Sanofi, Teva add to case for new bowel disease drug

BioPharma Dive

3 months ago

Sanofi, Teva add to case for new bowel disease drug

Sanofi and Teva report new outcomes from Phase IIb trial of duvakitug

Clinical Trials Arena

3 months ago

Sanofi and Teva report new outcomes from Phase IIb trial of duvakitug

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

GlobeNewswire

3 months ago

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

MT Newswires

3 months ago

Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

GlobeNewswire

3 months ago

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist

Motley Fool

3 months ago

Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $1,279,661, According to a Recent SEC Filing

Is Teva Pharmaceutical (TEVA) Trading at a Discount?

Insider Monkey

3 months ago

Is Teva Pharmaceutical (TEVA) Trading at a Discount?

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

GlobeNewswire

3 months ago

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

Investopedia

3 months ago

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

MT Newswires

3 months ago

Alvotech, Teva Pharmaceutical's Bionsimlar Eye Disorder Potential Treatment Accepted for FDA Review

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

GlobeNewswire

3 months ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

GuruFocus.com

3 months ago

Stanley Druckenmiller's Strategic Moves: A Closer Look at Teva Pharmaceutical Industries Ltd

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $2,886,565, According to a Recent SEC Filing

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva

Zacks

3 months ago

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

Benzinga

3 months ago

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

MT Newswires

3 months ago

Update: Axsome Therapeutics Shares Rise Following Deal to Settle Auvelity Patent Litigation With Teva

Share on Social Networks: